Ms. Lyons-Williams is currently the President and Chief Executive Officer of Abdera Therapeutics. Lori M. Lyons-Williams has served as a member of our board of directors since August 2020. Most recently, Lori Lyons-Williams served as chief operating officer of Neumora Therapeutics, Inc. Prior to that, from December 2016 to May 2020, Ms. Lyons-Williams served as Chief Commercial Officer at Dermira, Inc., a biopharmaceutical company, where she was responsible for the strategic, financial, and operational leadership of the company’s product portfolio. From January 2002 to August 2016, Ms. Lyons-Williams worked at Allergan, Inc., a public biotechnology company, where she held positions of increasing responsibility, most recently as Vice President, Sales & Marketing, Urology. Ms. Lyons-Williams also served as a member of the Allergan Commercial Leadership Team and the Operational Leadership Team. Since June 2019, Ms. Lyons-Williams has served on the board of directors of Five Prime Therapeutics, Inc. Ms. Lyons-Williams received a B.A. in Interdisciplinary Studies from Virginia Polytechnic Institute and State University and an M.B.A., Marketing from the Carlson School of Management at the University of Minnesota.